Indegene Limited has announced that a board meeting will be held on January 29, 2026, to review and approve the unaudited consolidated and standalone financial results for the quarter ended December 31, 2025 (Q3 2026). The meeting will also cover allotment under the RSU Scheme 2020. Trading window closure began on January 1, 2026, and will reopen 48 hours after results are declared.
Board Meeting for Q3 Results
A meeting of the Board of Directors of Indegene Limited is scheduled for January 29, 2026. The primary agenda is to consider and approve the company’s financial performance for the third quarter of fiscal year 2026.
Financial Results on the Agenda
The board will review both the unaudited consolidated and standalone financial results for the quarter ended December 31, 2025 (Q3 2026). This assessment will be conducted in accordance with Indian Accounting Standards (INDAS). The review will include the limited review report of the Auditors.
Other Business
In addition to the financial results, the board will also consider the allotment of shares under the RSU Scheme 2020.
Trading Window Closure
The trading window for company securities closed on January 01, 2026, and will reopen 48 hours following the declaration of the unaudited financial results for the quarter that ended December 31, 2025. This measure complies with regulations regarding insider trading.
Source: BSE
